{
  "$schema": "folio-library-entry/v1",
  "id": "10665-67839",
  "blocks": [
    {
      "id": "library/10665-67839/blocks/prose-sec-front-matter",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Front matter",
      "pageStart": 1,
      "pageEnd": 6,
      "target": "../sections/sec-front-matter.md",
      "narrative": null,
      "content": "SECOND MEETING OF THE\nGLOBAL WORKING GROUP\nON TB/HIV\n14-16 June 2002\nDurban, South Africa\nWORLD HEALTH ORGANIZATION\nWHO/CDS/TB/2002.311\nSECOND MEETING OF THE GLOBAL\nWORKING GROUP ON TB/HIV\n14-16 June 2002  \nDurban, South Africa\nStop TB Department, World Health Organization\n(on behalf of the Global Working Group on TB/HIV)\nWHO/CDS/TB/2002.311\nThis meeting was supported by the Global AIDS Program, Centers for Disease Control and\nPrevention, and by the Bureau for Global Health, Office of Health, Infectious Diseases and\nNutrition, the United States Agency for International Development and by WHO.",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Front matter of the report of the second meeting of the Global Working Group on TB/HIV, held in Durban, South Africa, on 14–16 June 2002, giving the document number, funders and the rapporteur and contributors. It notes that the working group is one of six under the Global Stop TB Partnership. The rest is the table of contents, listing the report's chapters and annexes on the agenda and participants.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-67839/blocks/prose-sec-000",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Glossary of abbreviations",
      "pageStart": 6,
      "pageEnd": 8,
      "target": "../sections/sec-000-glossary-of-abbreviations.md",
      "narrative": null,
      "content": "GLOSSARY OF ABBREVIATIONS\n3TC\nLAMIVUDINE\nABC\nABACAVIR\nACF\nACTIVE CASE FINDING\nAFRO\nWHO REGIONAL OFFICE FOR AFRICA\nAIDS\nACQUIRED IMMUNODEFICIENCY SYNDROME\nART\nANTI-RETROVIRAL TREATMENT\nARV\nANTI-RETROVIRAL\nCBO\nCOMMUNITY-BASED ORGANIZATION\nCD4\nANTIGEN IDENTIFYING T HELPER LYMPHOCYTES\nCDC-GAP\nGLOBAL AIDS PROGRAM, CENTERS OF DISEASE CONTROL AND PREVENTION\nCPT\nCO-TRIMOXAZOLE PREVENTIVE TREATMENT\nDOTS\nDIRECTLY-OBSERVED TREATMENT, SHORT COURSE\nEFV\nEFAVIRENZ\nFBO\nFAITH-BASED ORGANIZATION\nGDF\nGLOBAL DRUG FACILITY (FOR TB DRUGS)\nGFATM\nGLOBAL FUND TO FIGHT AIDS, TB AND MALARIA\nHAART\nHIGHLY ACTIVE ANTI-RETR",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "A glossary of abbreviations used in the report, followed by the start of the executive summary. The summary notes that the working group first met in 2001 and that the Durban meeting drew 130 participants from 35 countries. It sets out the meeting's objectives and mentions the country presentations, including Brazil's progress with antiretroviral therapy.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-67839/blocks/prose-sec-001",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Executive summary",
      "pageStart": 8,
      "pageEnd": 12,
      "target": "../sections/sec-001-executive-summary.md",
      "narrative": null,
      "content": "EXECUTIVE SUMMARY\nxecutive Summary\nE\nSeveral international agencies provided their perspectives: the World Bank, UNAIDS\nand USAID. Contributions were made by WHO regional offices (Africa, Southeast\nAsia and Western Pacific) and by WHO’s Department of HIV/AIDS/STIs.\nThere was a summary of international progress with the ProTEST initiative, the\nformal evaluation of which is still under way.\nIssues arising which were considered by the meeting to be of particular importance\nincluded:\n• the need to pull together information from all the TB/HIV projects that are \nongoing and ensure regular data coll",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Continues the executive summary with the perspectives of international agencies and WHO offices, the progress of the ProTEST initiative, and key issues raised, such as data collection, patients falling between TB and HIV programmes and adherence to preventive treatment. It reports that the draft guidelines on collaborative TB/HIV activities were endorsed subject to shortening, and introduces the main recommendations and the working group's background.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-67839/blocks/prose-sec-002",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Report",
      "pageStart": 12,
      "pageEnd": 12,
      "target": "../sections/sec-002-report.md",
      "narrative": null,
      "content": "epidemic and the need to step up action against it. The ProTEST approach to\naddressing TB/HIV was also discussed, and initial experiences with pilot ProTEST\nprojects were shared. The meeting reviewed and endorsed the WHO Strategic\nFramework to Decrease the Burden of TB/HIV.",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Recalls that the first meeting discussed the ProTEST approach and gave its endorsement to WHO's Strategic Framework for reducing the TB/HIV burden.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-67839/blocks/prose-sec-003",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "New developments",
      "pageStart": 12,
      "pageEnd": 12,
      "target": "../sections/sec-003-12-new-developments.md",
      "narrative": null,
      "content": "The secretariat managed the following developments between the first\nand the second WG meetings.\n• The Strategic Framework to Decrease the Burden of TB/HIV was published and \ndisseminated. Two WHO regional offices (EURO and WPRO) have made \nprogress in adapting the framework for their regions. \n• The Scientific Panel of the WG prepared guidelines for implementing \ncollaborative TB and HIV programme activities. These were presented to the \nsecond WG meeting at second-draft stage.\n• In February 2002 a protocol development workshop was held in Nairobi, where \neight countries (four from the origin",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Lists developments since the first meeting, such as publication of the Strategic Framework, draft guidelines on collaborative activities, a protocol workshop in Nairobi, TB modelling work, a new core group and updated estimates of HIV-associated TB.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-67839/blocks/prose-sec-004",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Background and objectives",
      "pageStart": 12,
      "pageEnd": 13,
      "target": "../sections/sec-004-1-background-and-objectives.md",
      "narrative": null,
      "content": "BACKGROUND AND OBJECTIVES\nBackground and objectives\n1 \neport\nR\n1.1\n1.2\n1 First Meeting of the Global Working Group on TB/HIV, 9-11 April 2001, Geneva, Switzerland.\nWHO/CDS/TB/2001.293\nSignificant changes in the policy environment that took place between the meetings\nincluded:\n• In April 2001, the UN Secretary General issued a call to action for the creation of \na Global Fund to fight HIV/AIDS, TB and Malaria (GFATM). Donor pledges to this \nfund have led to it becoming potentially a major new source of support for action \nagainst TB/HIV.  Amongst the countries represented at the Nairobi worksho",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Notes policy changes between the two meetings, including the creation of the Global Fund to Fight AIDS, Tuberculosis and Malaria, to which several countries had applied, and grants of TB drugs to 23 countries by the Global TB Drug Facility.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-67839/blocks/prose-sec-005",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Objectives",
      "pageStart": 13,
      "pageEnd": 14,
      "target": "../sections/sec-005-13-objectives.md",
      "narrative": null,
      "content": "The objectives of the second meeting were as follows.\n• To determine progress with joint TB and HIV activities and identify opportunities \nand constraints at international and national levels.\n• To produce practical recommendations for the expansion of joint actions against \nTB/HIV by TB and HIV/AIDS programmes.\n• To share experiences (at country and regional level) regarding both the \nprevalence of TB/HIV coinfection and efforts (both ProTEST and other activities) \nto control the overlapping epidemics of TB and HIV.\n• To identify ways of shifting the focus of the working group from global str",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Lists the meeting's objectives: reviewing progress with joint TB and HIV activities, making practical recommendations, sharing country experience, shifting the group's focus to country implementation, and finalising the collaborative activity guidelines.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-67839/blocks/prose-sec-006",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Country presentations",
      "pageStart": 14,
      "pageEnd": 16,
      "target": "../sections/sec-006-21-country-presentations.md",
      "narrative": null,
      "content": "Senegal \nDr Mandiaye Loume (Director of Health, Ministry of Health and Prevention\nSenegal) described efforts to integrate TB and AIDS control efforts. There have been\nan estimated 30,000 AIDS deaths in Senegal. HIV prevalence is estimated at 1.4%. \nTwo governing bodies were established to deal with HIV/AIDS: the National AIDS\nControl Committee (NACC) and the National AIDS Control Programme (NACP). The\nNACC has now been replaced by the National AIDS Control Council, headed by the\nPrime Minister. The NACP has sections for epidemic surveillance, diagnosis and\ncounselling, and treatment. Triple AR",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Summarises country presentations on TB/HIV from Senegal, Nigeria, Malawi and Cambodia, covering HIV prevalence, TB burden and treatment outcomes, programme structures and plans for collaboration. Plans mentioned include expanding counselling and testing, home-based care and preventive therapy.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-67839/blocks/prose-sec-007",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Presentations from international organizations",
      "pageStart": 16,
      "pageEnd": 22,
      "target": "../sections/sec-007-22-presentations-from-international-organization.md",
      "narrative": null,
      "content": "The World Bank\nDr K Hansen, Manager of the World Bank AIDS Campaign Team for\nAfrica, outlined the position of TB/HIV in the Bank’s Multi-country AIDS Programme\nfor Africa (MAP). US$1bn is available to scale up and intensify existing activities; 15\ncountries will be receiving $517m and programmes for a further 12 countries are\nalready in preparation. The Bank is thinking in terms of multi-sectoral, multi-\nstakeholder, long-term efforts that will strengthen the impact of AIDS control\nprogrammes and mitigate the impact of the disease in all sectors.\nMAP supports capacity building, expansion of re",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Summarises presentations from international organisations, including the World Bank's Multi-country AIDS Programme for Africa, UNAIDS advocacy and regional support, and USAID funding for TB/HIV. It also covers WHO regional offices, the WHO HIV/AIDS department and research on causes of death among people with HIV. A study is cited showing that cryptococcosis was the most common cause of death while TB caused few, and the section concludes that effective TB control offers the best immediate chance to improve survival.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-67839/blocks/prose-sec-008",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "ProTEST",
      "pageStart": 22,
      "pageEnd": 22,
      "target": "../sections/sec-008-31-protest.md",
      "narrative": null,
      "content": "A summary\nDr Philip Onyebujoh, from Stop TB, WHO, looked at achievements made\nso far in the ProTEST projects, supported by WHO, USAID and CDC-GAP.  The\nstrategies of ProTEST are: to reduce HIV transmission through quality VCT services,\npromotion of condoms, and, where possible, to treatment of STIs; to reduce TB\ntransmission through active case finding (ACF) and enhanced case-holding; to\nreduce TB reactivation through appropriate use of preventive therapy; to link HIV\nprevention services more closely to HIV care; and to increase collaboration between\nTB and HIV stakeholders.\nThe ProTEST projec",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Summarises achievements of the ProTEST projects in South Africa, Malawi and Zambia, which increased uptake of HIV counselling and testing and isoniazid preventive therapy but had poor adherence. It lists next steps, including phased implementation proposals from eight countries.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-67839/blocks/prose-sec-009",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Progress with joint TB/HIV interventions",
      "pageStart": 22,
      "pageEnd": 23,
      "target": "../sections/sec-009-3-progress-with-joint-tbhiv-interventions.md",
      "narrative": null,
      "content": "PROGRESS WITH JOINT TB/HIV INTERVENTIONS\nProgress with joint TB/HIV \ninterventions\n3 \n3.1\n3.1.1\nwith programmes supported by other agencies such as GFATM, CDC and USAID;\nthe holding of implementation workshops; capacity development; the standardisation\nof indicators; improved monitoring and evaluation; and the provision of technical\nassistance to countries implementing joint TB and HIV/AIDS programme activities.\nWHO/HQ will work with WHO, AFRO in bringing francophone countries into the PIA\nstrategy.\nFormal evaluation\nDr Peter Godfrey-Faussett and Dr Lilani Kumaranayake, both of the\nLondon Scho",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Outlines further next steps for phased implementation and describes the formal evaluation of ProTEST by the London School of Hygiene & Tropical Medicine, including cost-effectiveness analyses and behaviour surveys.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-67839/blocks/prose-sec-010",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Country experiences",
      "pageStart": 23,
      "pageEnd": 32,
      "target": "../sections/sec-010-32-country-experiences.md",
      "narrative": null,
      "content": "Ethiopia\nDr Berhane Kidane-Mariam (TB and Leprosy Programme Manager,\nEthiopia) spoke on TB/HIV collaborative efforts in Ethiopia, where only 52% of the\n65 million population are covered by health services. The estimated incidence of TB\nSECOND MEETING OF THE GLOBAL WORKING GROUP ON TB/HIV\n22\n3.1.2\n3.2\n3.2.1\nis 260/100,000 (all forms) and 109/100,000 (smear-positive). HIV prevalence stands\nat around 7%. There have been 105,781 reported AIDS cases. An estimated\n960,000 people are coinfected with TB/HIV. As regards treatment outcome, in 2000\nthe success rate for new sm+ PTB patients was 78% (SCC),",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Reports country experiences of joint TB/HIV activities in Ethiopia, Kenya, South Africa and other countries, with data on TB incidence, HIV prevalence, treatment success and programme challenges. It describes efforts to decentralise DOTS, expand testing and preventive therapy, and coordinate with partners. The section ends with break-out group conclusions that scaling up requires better staffing, adherence to prophylaxis and community involvement.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-67839/blocks/prose-sec-011",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Presentation of the guidelines",
      "pageStart": 32,
      "pageEnd": 32,
      "target": "../sections/sec-011-41-presentation-of-the-guidelines.md",
      "narrative": null,
      "content": "Dr Fabio Scano (Stop TB Department, WHO) reminded participants of the\nphilosophy of the global strategic framework to decrease the burden of TB/HIV: TB\nand HIV/AIDS programmes had largely pursued separate courses, despite\noverlapping TB/HIV epidemiology, but now there was a shift to a strengthened\nunified health sector strategy to control TB/HIV as an integral part of the response to\nHIV/AIDS. This new approach would involve: full implementation of the DOTS\nstrategy; additional interventions against TB (including intensified case-finding and\nTB preventive treatment); interventions to decrease",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Recalls the philosophy of the global TB/HIV framework, a shift from separate programmes to a unified strategy combining DOTS with TB prevention, HIV prevention and care for co-infected people.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-67839/blocks/prose-sec-012",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "activities",
      "pageStart": 32,
      "pageEnd": 33,
      "target": "../sections/sec-012-activities.md",
      "narrative": null,
      "content": "health districts, whilst recognising the need for reducing the burden of the two\noverlapping epidemics, may not be aware of potential collaborative activities and\ntheir benefits. The guidelines are intended for district policy-makers and health\nproviders (for whom they need to be simple, practical, evidenced-based and\nadaptable, to enable rational planning and priority setting) and national policy makers\nand programme managers (who need information for policy consensus and strategy,\nadvocacy and technical assistance). Collaborative TB and HIV programme activities\nshould build on TB and HIV int",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Presents the draft guidelines for collaborative TB/HIV activities, their target audiences of district and national decision-makers, the steps they recommend starting with a situation analysis, and the timetable for finalising them and developing training tools.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-67839/blocks/prose-sec-013",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Discussion",
      "pageStart": 33,
      "pageEnd": 34,
      "target": "../sections/sec-013-42-discussion.md",
      "narrative": null,
      "content": "Participants were agreed that the first volume of the guidelines would\nmake a valuable contribution to joint TB/HIV activities. (This volume provides\nbackground information and deals with the planning and implementation of joint\nprogrammes.)  Discussion largely focused on the usefulness of the second volume,\nwhich dealt with the evidence and experience base (from ProTEST and other\nsources) that was used to compile the activity guidelines. A range of views was\nexpressed. Some participants considered it to be useful and appropriate for\ninclusion in the guidelines as an annex. Others, especially",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Reports discussion of the guidelines, in which participants valued the first volume but disagreed on whether the second, evidence-based volume should be an annex or separate document. It was agreed to finish the guidelines within three months and make them simpler.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-67839/blocks/prose-sec-014",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Experience in Brazil",
      "pageStart": 34,
      "pageEnd": 34,
      "target": "../sections/sec-014-51-experience-in-brazil.md",
      "narrative": null,
      "content": "Dr Marco Vitória of the Brazilian STD/AIDS Programme described Brazil’s\naction against HIV/AIDS, focusing on strategies implemented to provide universal,\nfree anti-retroviral therapy to people living with HIV. This initiative began in 1991, with\nlimited distribution of ZDV capsules, and was extended in 1996, when a presidential\ndecree guaranteed free access to essential medication to all HIV-infected individuals.\nThe Ministry of Health has set up three AIDS task forces, which keep treatment\ncriteria under review in the light of new medical advances. Specific guidelines for\nTB/HIV coinfection h",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes Brazil's provision of free universal antiretroviral therapy since 1996, with about 113 000 people treated by 2001, low primary drug resistance and estimated savings of US$1.8 billion on hospital and outpatient care.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-67839/blocks/prose-sec-015",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Anti-retroviral treatment (ART)",
      "pageStart": 34,
      "pageEnd": 35,
      "target": "../sections/sec-015-5-anti-retroviral-treatment-art.md",
      "narrative": null,
      "content": "ANTI-RETROVIRAL TREATMENT (ART)\nAnti-retroviral treatment \n(ART)\n5 \n5.1\nThe Brazilian experience demonstrates that effective AIDS treatment is feasible in a\nmiddle-income country - Brazil’s GNP per capita for 1999 was $4790.  It has been\nshown that it can alter the natural history of coinfections, including TB.  Whether the\nsame results can be repeated in countries with significantly higher HIV prevalence\nrates, and lower incomes, remains to be seen.",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Notes that Brazil's experience shows AIDS treatment can work in a middle-income country, but questions whether this can be repeated in poorer countries with higher HIV prevalence.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-67839/blocks/prose-sec-016",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Experience in Malawi",
      "pageStart": 35,
      "pageEnd": 35,
      "target": "../sections/sec-016-52-experience-in-malawi.md",
      "narrative": null,
      "content": "The presentation of  Dr A Harries (see 3.2.4) included an account of\nMalawi’s experience with the use of ART. Challenges include safeguarding the drug\nsupply and ensuring routine laboratory monitoring. The criteria for starting ART are\ncrucial: too late in the decline of immune function and it will prevent little TB. If ART\nstarts two months after TB treatment, it will not address the high percentage of TB\ndeaths that occur in the first two months. There is a need for demonstration projects\nat district and country level, and for operational research to determine whether\nimmediate joint treatme",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Summarises Malawi's experience with antiretroviral therapy, highlighting drug supply, laboratory monitoring and the timing of treatment relative to TB therapy, and calls for demonstration projects and operational research.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-67839/blocks/prose-sec-017",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "WHO guidelines",
      "pageStart": 35,
      "pageEnd": 36,
      "target": "../sections/sec-017-53-who-guidelines.md",
      "narrative": null,
      "content": "Dr Charles Gilks (Department of HIV/AIDS/STIs, WHO) gave an overview\nof WHO’s recently published guidelines on the use of ART in resource-constrained\ncountries.1 Primary audiences for the guidelines are national treatment advisory\nboards, AIDS programme managers, and other senior policymakers. They are not\nintended to be a clinical manual for patient management. \nKey considerations in the development of the guidelines were:\n• the need for potent regimens (including at least three drugs) to prevent \nresistance and maximise benefit \n• standardisation to allow use in settings where HIV/AIDS speci",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Outlines WHO's new guidelines for antiretroviral therapy in resource-limited settings, aimed at policymakers, stressing potent three-drug regimens, standardisation, evidence-based recommendations and flexibility.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-67839/blocks/prose-sec-018",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Discussion",
      "pageStart": 36,
      "pageEnd": 38,
      "target": "../sections/sec-018-54-discussion.md",
      "narrative": null,
      "content": "The discussion that concluded this session centred on the WHO\nguidelines for ART. Participants expressed the need for a sharing of national and\nregional experience in adapting the guidelines to local situations. The need for\ntraining health workers in the use of ART was also stressed; WHO is already\nengaged in the development of guidelines. \nParticipants concluded that the data from Brazil (especially when combined with a\nSouth African report of an 80% reduction in TB incidence with the use of HAART2) -\nprovided ample evidence to justify efforts to increase access to ART. The WG\nshould, theref",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Reports discussion of the WHO antiretroviral guidelines, with calls for sharing adaptation experience and training health workers, and the conclusion that evidence from Brazil and South Africa justifies including HAART in joint TB/HIV activities.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-67839/blocks/prose-sec-019",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "The impact of available interventions",
      "pageStart": 38,
      "pageEnd": 38,
      "target": "../sections/sec-019-61-the-impact-of-available-interventions.md",
      "narrative": null,
      "content": "Christine Currie (Faculty of Mathematics, University of Southampton, UK)\npresented an epidemiological model of TB and HIV, and discussed its possible\napplication. There are two sub-models: one for people who are HIV negative or at an\nearly stage of the HIV disease, and one for people who are HIV-positive or are at a\nlater stage of the disease. The model can be used to explore the impact of a range\nof different interventions against TB and HIV. Data from the current situation in\nKenya was used to illustrate how it can be used in practice.  The interventions so far\nmodelled are: \n• Improving TB",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes a mathematical model of TB and HIV, illustrated with data from Kenya, used to explore the impact of interventions such as better TB cure and detection, latent TB treatment and antiretroviral therapy on TB incidence.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-67839/blocks/prose-sec-020",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Directions suggested by epidemiological modelling",
      "pageStart": 38,
      "pageEnd": 39,
      "target": "../sections/sec-020-6-directions-suggested-by-epidemiological-modell.md",
      "narrative": null,
      "content": "DIRECTIONS SUGGESTED BY EPIDEMIOLOGICAL MODELLING\nDirections suggested by \nepidemiological modelling\n6 \n6.1",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "A section heading on directions suggested by epidemiological modelling.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-67839/blocks/prose-sec-021",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Implications of an analysis of the TB and HIV epidemics",
      "pageStart": 39,
      "pageEnd": 41,
      "target": "../sections/sec-021-62-implications-of-an-analysis-of-the-tb-and-hiv.md",
      "narrative": null,
      "content": "epidemics\nDr Brian Williams (Stop TB, WHO) stressed the importance of taking a dynamic view\nof epidemics and for a broader perspective on the nature of TB/HIV interactions. In\nmany East and southern African countries it seems clear that even reasonably good\nDOTS programmes are in themselves not  sufficient to bring the rising epidemic of\nTB under control. Various other interventions which, if combined with DOTS, may\nsignificantly reduce the future burden of TB include: \n• the provision of TB preventive therapy for those with HIV;\n• TB mass treatment in situations where the incidence of TB is v",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Summarises an analysis of TB and HIV epidemic dynamics arguing that DOTS alone cannot control rising TB in East and southern Africa. It discusses added interventions such as preventive therapy, mass treatment and wide ART provision. Country projections suggest that only rapid DOTS expansion reduces TB, though the forecasts are uncertain.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-67839/blocks/prose-sec-022",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Discussion",
      "pageStart": 41,
      "pageEnd": 42,
      "target": "../sections/sec-022-63-discussion.md",
      "narrative": null,
      "content": "It was agreed that the presentations demonstrated the need for global and\nstrategic thinking and for regular monitoring of both the TB and the HIV epidemics.\nNational rates may be misleading given that there are very substantial intra-country\nvariations in both TB and HIV, and ranking countries simply according to their\nnational figures could in some cases be misleading. Given the size of some of the\nstates in India, for example, it will be important to collect and analyse data on a\nsubstantially finer geographical scale. \nClearly, the impact of ART on TB and other opportunistic infections wil",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Reports discussion of the modelling, stressing regular monitoring of both epidemics at finer geographical scales and the importance of when ART is started. It lists conclusions, including a step-wise approach to scaling up and attention to human resources and management.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-67839/blocks/prose-sec-023",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Constraints and recommendations to overcome them",
      "pageStart": 42,
      "pageEnd": 43,
      "target": "../sections/sec-023-7-constraints-and-recommendations-to-overcome-th.md",
      "narrative": null,
      "content": "CONSTRAINTS AND RECOMMENDATIONS TO OVERCOME THEM\nConstraints and \nrecommendations to \novercome them\n7 \n7.1",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "A section heading on constraints and recommendations to overcome them.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-67839/blocks/prose-sec-024",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Advocacy and Information, Education & Communication",
      "pageStart": 43,
      "pageEnd": 43,
      "target": "../sections/sec-024-72-advocacy-and-information-education-communicat.md",
      "narrative": null,
      "content": "Communication (Group 3)\nAdvocacy and IEC both have a vital part to play in addressing TB/HIV. However,\nrelatively few activities have yet been conducted and it is hard at this stage to make\nconcrete recommendations. More needs to be done to establish what actually\nworks.\nAdvocacy and IEC activities must articulate the problems and specify the targets in a\nsimple manner. Memorable slogans must be found!\nAdvocacy is needed to win political commitment. An important argument is that TB\ntreatment for PLWHA is the most affordable and cost-effective available intervention\nfor cutting AIDS mortality r",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Gives the advocacy and communication group's recommendations, such as simple messages, promoting TB treatment as a cost-effective way to cut AIDS deaths, and targeting audiences from UN theme groups and the Global Fund to health workers and communities.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-67839/blocks/prose-sec-025",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Surveillance, monitoring and evaluation",
      "pageStart": 43,
      "pageEnd": 44,
      "target": "../sections/sec-025-73-surveillance-monitoring-and-evaluation.md",
      "narrative": null,
      "content": "It was noted that collection of data had been stressed throughout the draft\nguidelines for collaborative TB/HIV activities. Data are required for effective\nprogrammes, and quality information can help win political commitment. The WG\nmade the following recommendations.\n• Indicators must be agreed to help set objectives and goals. WHO’s work to \nidentify suitable indicators must be completed as soon as possible and shared \nwith partners.\n• Surveillance should be systematic and regular. Data collected must be \ninterpreted and the findings disseminated. It is important that service providers \nrec",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Gives recommendations on surveillance, monitoring and evaluation, including agreed indicators, regular surveillance with feedback, measuring HIV prevalence among all TB patients and setting level-specific targets.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-67839/blocks/prose-sec-026",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Provision and improvement of clinical care",
      "pageStart": 44,
      "pageEnd": 45,
      "target": "../sections/sec-026-74-provision-and-improvement-of-clinical-care.md",
      "narrative": null,
      "content": "Diagnosis (both of TB and of HIV) must be strengthened in general health\nservices, and at TB, HIV and VCT treatment sites. This will require the following.\n• Strengthening the health system, particularly at district level. District health \nmanagement should play a more central role. Collaboration between medical and \nother sectors should be improved. \n• Acting in the community to increase awareness of signs/symptoms and \nencourage seeking treatment. Stigma against both conditions should be \naddressed. Traditional healers and pharmacy outlets should be included in \ncommunity action plans.\n• Rem",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Recommends strengthening TB and HIV diagnosis and clinical care through district health systems, community action against stigma, removing access barriers, better staffing and linking antiretroviral programmes with TB programmes.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-67839/blocks/prose-sec-027",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Scaling up joint activities",
      "pageStart": 45,
      "pageEnd": 46,
      "target": "../sections/sec-027-75-scaling-up-joint-activities.md",
      "narrative": null,
      "content": "(Group 6)\n• The WG urged WHO and partners to continue and expand their work to establish \nthe evidence base for TB/HIV interventions through phased implementation of \nnationally defined core activities.\n• Joint activities will vary but the following must always be considered for inclusion: \nsyndromic management of sexually transmitted infections, voluntary counselling \nand testing for HIV, active case finding, isoniazid preventive treatment, \ncotrimoxazole preventive treatment, treatment of opportunistic infections, home-\nbased care, prevention of mother to child transmission, anti-retroviral",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Recommends expanding the evidence base through phased implementation and lists core joint activities to consider, such as counselling and testing, preventive therapies and antiretroviral treatment. It stresses starting with a national situation analysis and protecting core DOTS programmes during scale-up.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-67839/blocks/prose-sec-028",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Summary of key recommendations",
      "pageStart": 46,
      "pageEnd": 55,
      "target": "../sections/sec-028-76-summary-of-key-recommendations.md",
      "narrative": null,
      "content": "1. In recognition that control of TB in high HIV prevalence settings requires full\nimplementation of the DOTS strategy and incorporation of additional joint TB/HIV\nactivities, the WG urges WHO: \n• to submit a resolution to the WHA in 2003 that urges governments to\nimplement an HIV/AIDS care strategy and country-level implementation of joint \nTB/HIV activities, as set out in the Global TB /HIV Strategic Framework\n• that the HIV/AIDS Department should finalise the development of its AIDS care \nstrategy and, without delay, share details of the principles on which it is based \n• that the Stop TB D",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Summarises the working group's key recommendations, including a proposed 2003 World Health Assembly resolution on joint TB/HIV activities, finalising the guidelines and an AIDS care strategy, and actions on funding, research and capacity. It ends with the meeting agenda (Annex 1) and the heading of the participant list (Annex 2).",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-67839/blocks/prose-sec-029",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "List of participants",
      "pageStart": 55,
      "pageEnd": 66,
      "target": "../sections/sec-029-annex-2-list-of-participants.md",
      "narrative": null,
      "content": "54\nDr P.I. Alade\nNational Action Committee on AIDS,\n(NACA), Special Assistant to Chairman,\nThe Presidency\nBlock 3A Room 1,44 - 1.48 (1st Floor)\nFederal Secretariat Complex, Abuja\nNigeria\nTel/Fax:+234-9-523-4253\nE-mail: nacaabj@yahoo.com\nor         nacaabj@email.com\nDr Helen Ayles\nProject Coordinator\nZAMBART Project\nc/o Department of Medicine\nUTH, P.O. Box 50110\nLusaka, Zambia\nTel: +260-1-254-710\nFax: +260-1-254-710\nE-mail: h.ayles@zamnet.zm \nor         h.ayles@doctors.org.uk\nMr Kevin Bellis\nManagement Advisor\nDFID - Southern Africa\nc/o National TB Control Programme\nDept of Health\nRoom 1817, Ha",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "The list of meeting participants, giving names, titles, organisations and contact details for people from national AIDS and tuberculosis programmes, research projects, donors and WHO, ending with WHO tuberculosis programme contact details printed with spaced-out letters.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    }
  ]
}
